It is getting harder to defend our patients' best interests,
but we cannot just surrender. We need the patient actively
involved to fully realize the benefits of insurance
contracts they have accepted. We need to remind our medical
societies to advocate vigorously for easier access to needed
care.1 If our readers can share their successful
advocacy methods, we would like to hear them. Clinical
science and public policy continue to evolve. We hope that
our article might help both practitioners and our colleagues
who work as carrier medical directors better to triangulate
the "middle ground" of best practices.
Disclosures: M. Raphaelson serves on the Scientific Advisory
Board and speakers' bureau and has received funding for
travel and speaker honoraria from Jazz Pharmaceutical;
practices sleep medicine and bills for related services; is
president of Marc Raphaelson, MD, PA, Inc., which collects
fees from governmental and commercial insurers; serves as
Medical Director for SleepMed, Inc., a for-profit entity
providing sleep medicine testing and treatment; and has
prepared affidavits for Sleep Information Systems, a now-
dissolved for-profit entity.
Reference
1. Raphaelson M, Brown DB. Sleep medicine practice
adaptations. Neurol Clin Pract 2014;4:63-70.
Disclosures: M. Raphaelson serves on the Scientific Advisory Board and speakers' bureau and has received funding for travel and speaker honoraria from Jazz Pharmaceutical; practices sleep medicine and bills for related services; is president of Marc Raphaelson, MD, PA, Inc., which collects fees from governmental and commercial insurers; serves as Medical Director for SleepMed, Inc., a for-profit entity providing sleep medicine testing and treatment; and has prepared affidavits for Sleep Information Systems, a now- dissolved for-profit entity.
Reference
1. Raphaelson M, Brown DB. Sleep medicine practice adaptations. Neurol Clin Pract 2014;4:63-70.